Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study-Reference-Cited by-同舟云学术

Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study

Published:2023-10 Issue: Volume:192 Page:113248
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Ben Khaled Najib^ORCID,Mörtl Bernhard,Beier Dominik,Reiter Florian P.,Pawlowska-Phelan Dorota,Teufel Andreas,Rössler Daniel,Schwade Daniel F.^ORCID,Philipp Alexander^ORCID,Kubisch Ilja,Ehmer Ursula,Geier Andreas,Lange Christian M.,Mayerle Julia,Berger-Thürmel Karin,De Toni Enrico N.,Munker Stefan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference59 articles.

1. Global cancer incidence and mortality rates and trends--an update;Torre;Cancer Epidemiol Biomarkers Prev,2016

2. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability;McGlynn;Clin Liver Dis,2015

3. Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma;Tovoli;Liver Cancer,2021

4. Disease burden, risk factors, and recent trends of liver cancer: a global country-level analysis;Huang;Liver Cancer,2021

5. Surveillance for hepatocellular carcinoma: current best practice and future direction;Kanwal;Gastroenterology,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events;JHEP Reports;2024-06

2. Letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study;European Journal of Cancer;2024-02

3. Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study;European Journal of Cancer;2024-02